The FDA is scheduled to hold a conference next week on advances in treating post-traumatic stress disorder.
A meta-analysis of 20 countries found that female doctors are at higher risk of suicide than the general population. (BMJ)
The Atlantic magazine explored the ketamine dilemma.
According to Neurocrine Biosciences, in a Phase 2 dose-finding study in adults with schizophrenia, the lowest dose of an investigational muscarinic M4 selective agonist resulted in a significant reduction in scores on the Positive and Negative Syndrome Scale compared to a placebo.
ProPublica has thoroughly investigated the state's mental health laws.
The Justice Department argued that Kentucky unnecessarily committed people with severe mental illnesses to psychiatric hospitals in violation of the Americans with Disabilities Act.
The investigational drug Zanamem failed to meet its primary objective in a placebo-controlled Phase IIa trial in patients with cognitive impairment and severe depression, but developer Actinogen Medical said the drug showed a significant effect on the secondary outcome of depression scores in a subgroup with baseline cognitive impairment.
Lifestyle psychiatry is all the rage, but what is it? (Forbes)
A cohort study found that inflammatory biomarkers such as white blood cell counts, haptoglobin, C-reactive protein, and immunoglobulin G were associated with an increased risk of developing psychiatric disorders. (JAMA Psychiatry)
The Surgeon General has issued recommendations calling for further support for the mental health and wellbeing of parents and carers.
More than 500 therapists spoke to ProPublica about a variety of factors that led them to go out-of-network.
Data from Epic Research found that older adults with diabetes who were diagnosed with Alzheimer's disease were more likely to have average HbA1c levels below 6.5% or above 8% in the five years prior to diagnosis compared with diabetic patients without Alzheimer's disease.
Rep. Yadira Carabeo (D-Colorado) said she seeks treatment for depression and is speaking out to end the stigma surrounding mental illness. (NBC News)
Kristen Monaco is a senior staff writer specializing in endocrinology, psychiatry and nephrology news. She is based in our New York City office and has been with us since 2015.
